SNN - Smith & Nephew SNATS - Stock & Dividends

Exchange: USA Stocks • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US83175M2052

Knee Implants, Hip Implants, Wound Care, Surgical Instruments

Smith & Nephew plc is a global medical technology company that designs, manufactures, and markets a wide range of innovative medical devices and services. With a rich history dating back to 1856, the company has established itself as a leader in the healthcare industry, operating through three main segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

In the Orthopaedics segment, Smith & Nephew offers a comprehensive portfolio of products for joint reconstruction, including knee and hip implants, as well as trauma and extremities products for the treatment of severe fractures and deformity correction procedures. These products are designed to improve patient outcomes and enhance the quality of life for individuals with musculoskeletal conditions.

The Sports Medicine & ENT segment focuses on providing cutting-edge solutions for sports medicine joint repair, including instruments, technologies, and implants for minimally invasive surgery. This range of products enables surgeons to treat soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. Additionally, the company offers a suite of arthroscopic enabling technologies, such as fluid management equipment, high-definition cameras, and hand instruments, to facilitate visualization and treatment inside the joints.

In the Advanced Wound Management segment, Smith & Nephew provides a comprehensive range of products for the treatment and prevention of acute and chronic wounds. This includes advanced wound care products, such as leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds, as well as advanced wound bioactives, like biologics and other bioactive technologies for debridement and dermal repair/regeneration. The company also offers regenerative medicine products, including skin, bone graft, and articular cartilage substitutes, as well as advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems.

Smith & Nephew's products and services are designed to support healthcare providers in delivering high-quality patient care. With a strong commitment to innovation and customer satisfaction, the company continues to push the boundaries of medical technology, improving the lives of millions of people around the world. Headquartered in Watford, the United Kingdom, Smith & Nephew plc is a global leader in the medical technology industry.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for SNN - Smith & Nephew SNATS  - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for SNN - Smith & Nephew SNATS  - Stock & Dividends

SNN Stock Overview

Market Cap in USD 12,297m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1999-11-16

SNN Stock Ratings

Growth 5y -32.9
Fundamental 55.1
Dividend 36.1
Rel. Performance vs Sector -0.23
Analysts 4.50/5
Fair Price Momentum 28.21 USD
Fair Price DCF 13.16 USD

SNN Dividends

Dividend Yield 12m 2.59%
Yield on Cost 5y 1.87%
Dividends CAGR 5y 0.60%
Payout Consistency 95.6%

SNN Growth Ratios

Growth 12m -2.72%
Growth Correlation 12m 7%
Growth Correlation 3m 50%
CAGR 5y -6.30%
CAGR/Mean DD 5y -0.21
Sharpe Ratio 12m -0.36
Alpha vs SP500 12m -24.88
Beta vs SP500 5y weekly 1.09
ValueRay RSI 92.19
Volatility GJR Garch 1y 21.11%
Price / SMA 50 10.17%
Price / SMA 200 12.79%
Current Volume 633.5k
Average Volume 20d 1025k

External Links for SNN Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of SNN stocks?
As of July 27, 2024, the stock is trading at USD 28.93 with a total of 633,521 shares traded.
Over the past week, the price has changed by +2.26%, over one month by +16.61%, over three months by +18.32% and over the past year by -1.75%.
What are the forecast for SNN stock price target?
According to ValueRays Forecast Model, SNN Smith & Nephew SNATS will be worth about 31.2 in July 2025. The stock is currently trading at 28.93. This means that the stock has a potential upside of +7.78%.
Issuer Forecast Upside
Wallstreet Target Price 30.5 5.32
Analysts Target Price 31.3 8.30
ValueRay Target Price 31.2 7.78